Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Outcome of Extra-Nodal Follicular Lymphoma Affected By Selection of Induction Chemoimmunotherapy and Maintenance Rituximab - Real-World Retrospective Study

Blood (2024) 144 (Supplement 1): 6277.

https://doi.org/10.1182/blood-2024-193417

Published: 2024

Journal Articles

The Endothelial Activation and Stress Index (EASIX) Score Improves Risk Stratification for Double Expressor Diffuse Large B-Cell Lymphoma (DEL)

Jing Yuan Tan, Jason Yongsheng Chan, Shin Yeu Ong, Chandramouli Nagarajan, Yunxin Chen, Francesca Lorraine Wei Inng Lim, Nicholas Francis Grigoropoulos, Ya Hwee Tan, Joshua Tian Ming Hoe, Jianbang Chiang, Esther Chang, Eileen Poon, Nagavalli Somasundaram, Miriam Tao, Yeow Tee Goh, Soon Thye Lim, Lawrence Cheng Kiat Ng

Blood (2024) 144 (Supplement 1): 6450.

https://doi.org/10.1182/blood-2024-194684

Published: 2024

Journal Articles

A Clinical Prognostic Index for Angioimmunoblastic T Cell Lymphoma in an Asian Multi-Centre Study

Esther Chang, Valerie Shiwen Yang, Shin Yeu Ong, Hilda Kang, Ya Hwee Tan, Jianbang Chiang, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamad Farid, Tiffany Tang, Miriam Tao, Lay Poh Khoo, Choon Kiat Ong, Soon Thye Lim, Jason Yongsheng Chan

Blood (2021) 138 (Supplement 1): 2453.

https://doi.org/10.1182/blood-2021-147679

Published: 2021

Journal Articles

Ambiguous Diagnosis of Nodal T-Cell Lymphomas with T-Follicular Helper (TFH) Phenotype and Hodgkin Lymphoma - a Multicenter Pilot Study

Blood (2021) 138 (Supplement 1): 1403.

https://doi.org/10.1182/blood-2021-149358

Published: 2021

Journal Articles

Treatment Outcomes of Early-Stage Natural-Killer/T-Cell Lymphomas Treated with Chemoradiotherapy: Data from 3 Tertiary Cancer Centres in Singapore

Ya Hwee Tan, MBBS, MRCP, Siqin Zhou, MSc, Liu Xin, Soon Thye Lim, MBBS, MRCP, FAMS, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Daryl Tan, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Mohamad Farid, MBBS, MMed, MRCP, Colin Phipps Diong, Yuh Shan Lee, Shin-Yeu Ong, MD, Nicholas Francis Grigoropoulos, Kheng Wei Yeoh, MBBS, MSc, MRCP, MPH, FRCR (Clinical Oncology), Nagavalli Somasundaram, MBBS, MRCP, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Jason Yongsheng Chan, MBBS, MRCP, Esther Wei Yin Chang, MD MRCP, Tiffany Tang, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 5274.

https://doi.org/10.1182/blood-2019-125085

Published: 2019

Journal Articles

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in the Rituximab Era

Ryan Mao Heng Lim, Natalie Pei Xin Chan, Lay Poh Khoo, BSc, Chee Leong Cheng, FRCPA, FRCPath, MBBS, Leonard Tan, MBBS, MRCPath, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Nagavalli Somasundaram, MBBS, MRCP, Mohamad Farid, MBBS, MMed, MRCP, Tiffany Tang, MBBS, MRCP, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Jason Yongsheng Chan, MBBS

Blood (2018) 132 (Supplement 1): 5396.

https://doi.org/10.1182/blood-2018-99-114792

Published: 2018

Journal Articles

Differential Outcomes of Synchronous and Metachronous Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma

Natalie Pei Xin Chan, Ryan Mao Heng Lim, Lay Poh Khoo, BSc, Chee Leong Cheng, FRCPA, FRCPath, MBBS, Leonard Kwan Cheong Tan, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Nagavalli Somasundaram, MBBS, MRCP, Mohamad Farid, MBBS, MRCP (UK), Tiffany Tang, MBBS, MRCP, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Soon Thye Lim, Jason Yongsheng Chan, MBBS

Blood (2018) 132 (Supplement 1): 5409.

https://doi.org/10.1182/blood-2018-99-116231

Published: 2018

Journal Articles

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Blood (2018) 132 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2018-99-118364

Published: 2018

Journal Articles

Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies

Blood (2017) 130 (Supplement 1): 1564.

https://doi.org/10.1182/blood.V130.Suppl_1.1564.1564

Published: 2017

Journal Articles

A Phase II Study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in Patients with Newly Diagnosed Natural-Killer/T-Cell Lymphoma

Tiffany Tang, MD, Kevin Tay, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Mohamad Farid, MD, Soon Thye Lim, MD

Blood (2016) 128 (22): 5353.

https://doi.org/10.1182/blood.V128.22.5353.5353

Published: 2016

Journal Articles

Time from Diagnosis to Initiation of Curative Chemotherapy Affects Outcomes in DLBCL - Data from a Large Asian Cohort

Colin Phipps, MBBS, MRCP, FRCPath, Yuh Shan Lee, MBBS, MRCP, FRCPath, Chandramouli Nagarajan, MBBS, MD MRCP, Yunxin Chen, MBBS, MRCP, FRCPath, Allan ZK Goh, Lay Poh Khoo, BSc, Kevin Tay, MD, Miriam Tao, MD, Richard Quek, Tiffany Tang, MD, Mohamad Farid, MD, Soon Thye Lim, MBBS, MRCP, Sathish Kumar Gopalakrishnan, FRCPath, Nicholas F Grigoropoulos, MRCP, FRCPath, Yvonne Loh, MBBS, MRCP, Daryl Tan, MBBS, MRCP, William YK Hwang, MBBS, MRCP, FRCP, Yeow Tee Goh, MD

Blood (2016) 128 (22): 1871.

https://doi.org/10.1182/blood.V128.22.1871.1871

Published: 2016

Journal Articles

A Case of Two Young Brothers with Natural-Killer/T-Cell Lymphoma

Tiffany Tang, MD, Maarja-Liisa Nairismagi, PhD, Alvin Yu Jin Ng, PhD, Byrappa Venkatesh, Joanne Ngeow, MD, Shao-Tzu Li, Yurike Laurensia, BSc, Jing Quan Lim, PhD, Sanjanaa Nagarajan, MSc, Burton Chia, Jing Tan, PhD, Yeow Tee Goh, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Mohamad Farid, MD, Soon Thye Lim, MD, Choon Kiat Ong

Blood (2016) 128 (22): 5293.

https://doi.org/10.1182/blood.V128.22.5293.5293

Published: 2016

Journal Articles

Role of Consolidation High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplant (ASCT) Support in Patients with Peripheral T-Cell Lymphoma Who Achieved Complete Remission (CR1) Following First Line Induction Chemotherapy

Lay Poh Khoo, BSc, Tiffany Tang, MD, Suk Teng Chin, BSc, Jeslin Ha, BSc, Colin Phipps, MBBS, MRCP, FRCPath, Yuh Shan Lee, MBBS, MRCP, FRCPath, Mohamad Farid, MD, Kevin Tay, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Soon Thye Lim, MD

Blood (2016) 128 (22): 4640.

https://doi.org/10.1182/blood.V128.22.4640.4640

Published: 2016

Journal Articles

A Multi-Center, Non-Randomized Phase 2 Study of Ofatumumab in Combination with ICE-Chemotherapy (O-ICE) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Tiffany Tang, MBBS, MRCP, Cindy Lim, Miriam Tao, MBBS, MRCP, Richard Quek, MBBS, MRCP, Mohamad Farid, Won Seog Kim, MDPhD, Seok Jin Kim, MD PhD, Seong Hyun Jeong, Jong-Ho Won, MD, Nooraisyah Ismail, Soon Thye Lim, MBBS, MRCP

Blood (2014) 124 (21): 5465.

https://doi.org/10.1182/blood.V124.21.5465.5465

Published: 2014

Journal Articles

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkin’s Lymphoma

Joycelyn Jie Xin Lee, MBBS, Glorijoy Shi En Tan, MBBS, Chee Hian Tan, MBBS, Summer Pan, Chiea Chuen Khor, Jianjun Liu, Jia Nee Foo, Soo Yong Tan, MBBS, MRCPath, Siok Bian Ng, Miriam Tao, MBBS, MRCP, Soon Thye Lim, MBBS, MRCP, Tiffany Tang, MBBS, MRCP

Blood (2013) 122 (21): 4249.

https://doi.org/10.1182/blood.V122.21.4249.4249

Published: 2013

Journal Articles

Prognostic Significance Of JAK3 Activating Mutations In Natural-Killer/T-Cell Lymphomas

Tiffany Tang, MBBS, MRCP, Summer Pan, Ghee Chong Koo, PhD, Soo Yong Tan, MBBS, MRCPath, Cedric Ng, Vikneswari Rajasegaran, Choon Kiat Ong, Leonard Tan, MBBS, MRCPath, Kevin Tay, MD, Miriam Tao, MBBS, MRCP, Richard Quek, MBBS, MRCP, Kheng Wei Yeoh, MD, Bin Tean Teh, MD, PhD, Soon Thye Lim, MBBS, MRCP

Blood (2013) 122 (21): 4337.

https://doi.org/10.1182/blood.V122.21.4337.4337

Published: 2013

Journal Articles

Gene Expression Profiling Identifies the JAK/STAT and NFκB Pathways to Be Important in Peripheral T-Cell Lymphomas and Natural-Killer T-Cell Lymphomas

Tiffany Tang, MBBS, MRCP, George Allen, Ghee Chong Koo, PhD, Kevin Tay, MD, Daryl Tan, MBBS, MRCP, Richard Quek, MBBS, MRCP, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Bin Tean Teh, MD, PhD, Soon Thye Lim, MBBS, MRCP

Blood (2011) 118 (21): 2658.

https://doi.org/10.1182/blood.V118.21.2658.2658

Published: 2011

Journal Articles

Dual Translocation Is An Independent Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma,

Kevin Tay, MD, Gillianne Lai, Elaine J Chua, Whee Sze Ong, Tiffany Tang, MBBS, MRCP, Richard Quek, MBBS, MRCP, Daryl Tan, MBBS, MRCP, Leonard Tan, MBBS, MRCPath, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Soon Thye Lim, MBBS, MRCP

Blood (2011) 118 (21): 3683.

https://doi.org/10.1182/blood.V118.21.3683.3683

Published: 2011

Journal Articles

Should Intensive Chemotherapy Be Required for All Mantle Cell Lymphoma Patients

Zhen Tang Lao, MBBS, MRCP, Kathleen Khoo, Jasmine Koh, Whee Sze Ong, Tiffany Tang, MBBS, MRCP, Richard Quek, MBBS, MRCP, Leonard Tan, MBBS, MRCPath, Daryl Tan, MBBS, MRCP, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Soon Thye Lim, MBBS, MRCP, Kevin Tay, MD

Blood (2011) 118 (21): 5188.

https://doi.org/10.1182/blood.V118.21.5188.5188

Published: 2011

Journal Articles

Follicular Lymphoma with Diffuse Large B-Cell Component At Initial Diagnosis Appears to Be Associated with a Loss of BCL2 Translocation and Inferior Progression Free Survival

Kevin Tay, MD, Yee Siang Shew, MBBS, Yu Lin Gao, Whee Sze Ong, Tiffany Tang, MBBS, MRCP, Richard Quek, MBBS, MRCP, Daryl Tan, MBBS, MRCP, Leonard Tan, MBBS, MRCPath, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Soon Thye Lim, MBBS, MRCP

Blood (2011) 118 (21): 1577.

https://doi.org/10.1182/blood.V118.21.1577.1577

Published: 2011

NARROW

Outcome of Extra-Nodal Follicular Lymphoma Affected By Selection of Induction Chemoimmunotherapy and Maintenance Rituximab - Real-World Retrospective Study

The Endothelial Activation and Stress Index (EASIX) Score Improves Risk Stratification for Double Expressor Diffuse Large B-Cell Lymphoma (DEL)

A Clinical Prognostic Index for Angioimmunoblastic T Cell Lymphoma in an Asian Multi-Centre Study

Ambiguous Diagnosis of Nodal T-Cell Lymphomas with T-Follicular Helper (TFH) Phenotype and Hodgkin Lymphoma - a Multicenter Pilot Study

Treatment Outcomes of Early-Stage Natural-Killer/T-Cell Lymphomas Treated with Chemoradiotherapy: Data from 3 Tertiary Cancer Centres in Singapore

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in the Rituximab Era

Differential Outcomes of Synchronous and Metachronous Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies

A Phase II Study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in Patients with Newly Diagnosed Natural-Killer/T-Cell Lymphoma

Time from Diagnosis to Initiation of Curative Chemotherapy Affects Outcomes in DLBCL - Data from a Large Asian Cohort

A Case of Two Young Brothers with Natural-Killer/T-Cell Lymphoma

Role of Consolidation High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplant (ASCT) Support in Patients with Peripheral T-Cell Lymphoma Who Achieved Complete Remission (CR1) Following First Line Induction Chemotherapy

A Multi-Center, Non-Randomized Phase 2 Study of Ofatumumab in Combination with ICE-Chemotherapy (O-ICE) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkin’s Lymphoma

Prognostic Significance Of JAK3 Activating Mutations In Natural-Killer/T-Cell Lymphomas

Gene Expression Profiling Identifies the JAK/STAT and NFκB Pathways to Be Important in Peripheral T-Cell Lymphomas and Natural-Killer T-Cell Lymphomas

Dual Translocation Is An Independent Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma,

Should Intensive Chemotherapy Be Required for All Mantle Cell Lymphoma Patients

Follicular Lymphoma with Diffuse Large B-Cell Component At Initial Diagnosis Appears to Be Associated with a Loss of BCL2 Translocation and Inferior Progression Free Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only